Results 141 to 150 of about 5,054 (206)

Ostraceous psoriasis in end-stage renal disease: A delayed phenotype switch from dupilumab treated with guselkumab. [PDF]

JAAD Case Rep
Craver AE, McKenzie P, Hanly A, Vesely MD.   +3 more
europepmc   +1 more source

The IL-23/-17 Axis in PsA: What Have We Learned in the Last 20 Years? [PDF]

Mediterr J Rheumatol
Theodoridou F, Katsouli O, Fragoulis GE.
europepmc   +1 more source

Effects of Guselkumab on Structural Damage Progression in Patients with Active Psoriatic Arthritis. [PDF]

Adv Ther
Ritchlin CT, Coates LC, Mease PJ, van der Heijde D, Rahman P.   +4 more
europepmc   +1 more source

Efficacy and Safety of Guselkumab in Real-World Evidence: A Systematic Review and Meta-Analysis. [PDF]

J Clin Med
Dodero-Anillo JM, Fernandez-Pujol-Marzo M, Martinez MJP, Ruiz-Villaverde R, Armario-Hita JC.   +4 more
europepmc   +1 more source

Efficacy and Safety of Guselkumab in Participants With Active Psoriatic Arthritis After Inadequate Response to One Prior Tumor Necrosis Factor Inhibitor: Week-24 Results of a Phase 3, Randomized, Placebo-Controlled Study. [PDF]

Arthritis Rheumatol
Ogdie A, Merola JF, Mease PJ, Ritchlin CT, Scher JU, Lafferty KP, Chan D, Chakravarty SD, Langholff W, Wang Y, Shao J, Krol Y, Gottlieb AB.   +12 more
europepmc   +1 more source

Safe seroconversion after receiving measles, mumps, and rubella live vaccine during guselkumab treatment for psoriasis. [PDF]

JAAD Case Rep
Kim K, Kirshen C.
europepmc   +1 more source

A Rapid and Marked Response to Guselkumab in Extensive Plaque Psoriasis: A Case Report. [PDF]

Cureus
Oropesa E, Aguila YL, Pena Reina BD, Vargas Batista ID, Pereda Gonzalez Y, Milanes Chongon MD.   +5 more
europepmc   +1 more source

Real-world effectiveness of guselkumab for induction of remission in Crohn's disease: a prospective multicenter cohort study with propensity score-matched comparison to risankizumab. [PDF]

Crohns Colitis 360
Al Hosani M, Al Hosani N, Alzaabi MN, Alahmad MA, Omar NM, Oribiana CC, Ahmed EF, Ahmed I, Chitra Kumar KK, Hanif S, Barakat KIE, Elsayed KOE, Quraishi MN.   +12 more
europepmc   +1 more source

Multiomic characterisation of the clinical efficacy of guselkumab induction therapy in ulcerative colitis. [PDF]

BMJ Open Gastroenterol
Hart A, Sridhar S, Venkat S, Lee T, Rusbuldt JJ, Richards D, Sisk C, Horowitz D, Tomsho L, Kannan AK, Ruane D, Van den Berge K, Rubin DT, Sands BE, De Hertogh G, Huang KG, Germinaro M, Cua D, Waterworth D, Freeman TC, Vetter ML, McRae B, Verstockt B, Branigan P.   +23 more
europepmc   +1 more source

A Retrospective Review of Real-World Patterns of Biologic Use in Dermatology Across Metropolitan, Regional and Rural Settings. [PDF]

Australas J Dermatol
Abeysekera N, Sibanda K, Park C, Griffin J, Wagner G, Banney L.   +5 more
europepmc   +1 more source